In vivo CRISPR-Cas9 inhibition of hepatic LDH as treatment of primary hyperoxaluria

1. Martinez-Turrillas, R.
2. Martin-Mallo, A.
3. Rodriguez-Diaz, S.
4. Zapata-Linares, N.
5. Rodriguez-Marquez, P.
6. San Martin-Uriz, P.
7. Vilas-Zornoza, A.
8. Calleja-Cervantes, M.E.
9. Salido, E.
10. Prosper, F.
11. Rodriguez-Madoz, J.R.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1016/J.OMTM.2022.03.006 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

• 

Data source: Scopus